{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:06:26Z","timestamp":1775217986720,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016198","name":"Idorsia Pharmaceuticals Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.preghy.2026.101431","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:14:18Z","timestamp":1770797658000},"page":"101431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Placental transfer of the novel endothelin-1 receptor antagonist aprocitentan"],"prefix":"10.1016","volume":"43","author":[{"given":"Anna C.M.","family":"Kluivers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavi S.","family":"Harhangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunbo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte E.","family":"van der Meeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Broekhuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Delahaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.preghy.2026.101431_b0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, challenges, and Perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.preghy.2026.101431_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"issue":"4","key":"10.1016\/j.preghy.2026.101431_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11906-018-0828-4","article-title":"The Endothelin System: a critical player in the Pathophysiology of Preeclampsia","volume":"20","author":"Granger","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"2 Pt 2","key":"10.1016\/j.preghy.2026.101431_b0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.HYP.37.2.485","article-title":"Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure","volume":"37","author":"Alexander","year":"2001","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.preghy.2026.101431_b0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ydbio.2009.01.005","article-title":"Elucidating timing and function of endothelin-a receptor signaling during craniofacial development using neural crest cell-specific gene deletion and receptor antagonism","volume":"328","author":"Ruest","year":"2009","journal-title":"Dev. Biol."},{"issue":"5","key":"10.1016\/j.preghy.2026.101431_b0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdrb.21021","article-title":"An evaluation of reproductive and developmental toxicity of sitaxentan (thelin) in rats","volume":"95","author":"Cross","year":"2012","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"issue":"2\u20133","key":"10.1016\/j.preghy.2026.101431_b0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.lfs.2003.09.027","article-title":"Pharmacological knockout of endothelin ET(A) receptors","volume":"74","author":"Taniguchi","year":"2003","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.preghy.2026.101431_b0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/CS20190464","article-title":"Endothelin receptor antagonism during preeclampsia: a matter of timing?","volume":"133","author":"Hitzerd","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"issue":"3","key":"10.1016\/j.preghy.2026.101431_b0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.119.14183","article-title":"Transfer and vascular effect of endothelin receptor antagonists in the human placenta","volume":"75","author":"Hitzerd","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.preghy.2026.101431_b0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14740338.2014.859674","article-title":"Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension","volume":"13","author":"Dingemanse","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"issue":"10367","key":"10.1016\/j.preghy.2026.101431_b0055","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","article-title":"Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial","volume":"400","author":"Schlaich","year":"2022","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.preghy.2026.101431_b0060","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s40262-021-01049-3","article-title":"A Population Pharmacokinetic Model of Macitentan and its active Metabolite Aprocitentan in healthy Volunteers and patients with Pulmonary Arterial Hypertension","volume":"60","author":"Bartolucci","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.preghy.2026.101431_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ebiom.2019.06.007","article-title":"Placental effects and transfer of sildenafil in healthy and preeclamptic conditions","volume":"45","author":"Hitzerd","year":"2019","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.preghy.2026.101431_b0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"6","key":"10.1016\/j.preghy.2026.101431_b0075","doi-asserted-by":"crossref","first-page":"H2204","DOI":"10.1152\/ajpheart.1999.276.6.H2204","article-title":"Hemodynamic model for analysis of Doppler ultrasound indexes of umbilical blood flow","volume":"276","author":"Kleiner-Assaf","year":"1999","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology."},{"issue":"1","key":"10.1016\/j.preghy.2026.101431_b0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.placenta.2004.11.008","article-title":"Reactivity of human placental chorionic plate vessels is modified by level of oxygenation: differences between arteries and veins","volume":"27","author":"Wareing","year":"2006","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.preghy.2026.101431_b0085","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0002-9378(94)70311-6","article-title":"Functional characteristics of small placental arteries","volume":"170","author":"McCarthy","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2026.101431_b0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.placenta.2008.01.011","article-title":"Maternal asthma and placental morphometry: effects of severity, treatment and fetal sex","volume":"29","author":"Mayhew","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2026.101431_b0095","first-page":"682","article-title":"Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics","volume":"5","author":"Sand","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.preghy.2026.101431_b0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1095\/biolreprod.105.050021","article-title":"Evidence for a clathrin-mediated recycling of albumin in human term placenta","volume":"75","author":"Lambot","year":"2006","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.preghy.2026.101431_b0105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.12815","article-title":"Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models","volume":"81","author":"De Sousa","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"25","key":"10.1016\/j.preghy.2026.101431_b0110","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1080\/14767058.2021.2005565","article-title":"A review of ex vivo placental perfusion models: an underutilized but promising method to study maternal-fetal interactions","volume":"35","author":"Calis","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.preghy.2026.101431_b0115","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/HYPERTENSIONAHA.119.14504","article-title":"Randomized Dose-Response Study of the New dual Endothelin Receptor Antagonist Aprocitentan in Hypertension","volume":"75","author":"Verweij","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.preghy.2026.101431_b0120","doi-asserted-by":"crossref","DOI":"10.1080\/08037051.2024.2424824","article-title":"a new emerging prospect in the pharmacotherapy of hypertension","volume":"33","author":"Naseralallah","year":"2024","journal-title":"Blood Press."},{"key":"10.1016\/j.preghy.2026.101431_b0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.reprotox.2016.04.017","article-title":"Maternal\u2013fetal transfer of indocyanine green across the perfused human placenta","volume":"62","author":"Rubinchik-Stern","year":"2016","journal-title":"Reprod. Toxicol."},{"issue":"11","key":"10.1016\/j.preghy.2026.101431_b0130","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.placenta.2015.08.012","article-title":"l-arginine prevents hypoxia-induced vasoconstriction in dual-perfused human placental cotyledons","volume":"36","author":"Bednov","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2026.101431_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.placenta.2022.05.003","article-title":"Ex vivo dual perfusion of an isolated human placenta cotyledon: Towards protocol standardization and improved inter-centre comparability","volume":"126","author":"Schneider","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2026.101431_b0140","series-title":"Pathology of the Human Placenta","author":"K. Benirschke GJB, R.N. Baergen","year":"2012"},{"issue":"2","key":"10.1016\/j.preghy.2026.101431_b0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajog.2022.08.010","article-title":"Placental pathology is necessary to understand common pregnancy complications and achieve an improved taxonomy of obstetrical disease","volume":"228","author":"Redline","year":"2023","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778926000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:29:55Z","timestamp":1775215795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778926000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S2210778926000188"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101431","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental transfer of the novel endothelin-1 receptor antagonist aprocitentan","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2026.101431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101431"}}